Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Recovery after stem-cell transplantation for hematologic diseases.

Lee SJ, Fairclough D, Parsons SK, Soiffer RJ, Fisher DC, Schlossman RL, Antin JH, Weeks JC.

J Clin Oncol. 2001 Jan 1;19(1):242-52.

PMID:
11134219
[PubMed - indexed for MEDLINE]
Free Article
2.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
[PubMed - indexed for MEDLINE]
3.

Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria.

Burdach S, van Kaick B, Laws HJ, Ahrens S, Haase R, Körholz D, Pape H, Dunst J, Kahn T, Willers R, Engel B, Dirksen U, Kramm C, Nürnberger W, Heyll A, Ladenstein R, Gadner H, Jürgens H, Go el U.

Ann Oncol. 2000 Nov;11(11):1451-62. Review.

PMID:
11142486
[PubMed - indexed for MEDLINE]
Free Article
4.

Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation.

Worel N, Biener D, Kalhs P, Mitterbauer M, Keil F, Schulenburg A, Höcker P, Dieckmann K, Fischer G, Rosenmayr A, Linkesch W, Hinterberger W, Lechner K, Greinix HT.

Bone Marrow Transplant. 2002 Nov;30(9):619-26.

PMID:
12407437
[PubMed - indexed for MEDLINE]
Free Article
5.

The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation.

Hjermstad MJ, Evensen SA, Kvaløy SO, Loge JH, Fayers PM, Kaasa S.

Psychooncology. 2003 Dec;12(8):803-13.

PMID:
14681953
[PubMed - indexed for MEDLINE]
6.

Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies.

Branson K, Chopra R, Kottaridis PD, McQuaker G, Parker A, Schey S, Chakraverty RK, Craddock C, Milligan DW, Pettengell R, Marsh JC, Linch DC, Goldstone AH, Williams CD, Mackinnon S.

J Clin Oncol. 2002 Oct 1;20(19):4022-31.

PMID:
12351600
[PubMed - indexed for MEDLINE]
Free Article
7.

A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation.

Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H, Kaasa S.

Bone Marrow Transplant. 2004 Aug;34(3):257-66.

PMID:
15170167
[PubMed - indexed for MEDLINE]
8.

Optimistic expectations and survival after hematopoietic stem cell transplantation.

Lee SJ, Loberiza FR, Rizzo JD, Soiffer RJ, Antin JH, Weeks JC.

Biol Blood Marrow Transplant. 2003 Jun;9(6):389-96.

PMID:
12813447
[PubMed - indexed for MEDLINE]
9.

Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia.

Messerer D, Engel J, Hasford J, Schaich M, Ehninger G, Sauerland C, Büchner T, Schumacher A, Krahl R, Niederwieser D, Krauter J, Ganser A, Creutzig U, Döhner H, Schlenk RF; German AML Intergroup.

Haematologica. 2008 Jun;93(6):826-33. doi: 10.3324/haematol.11987. Epub 2008 May 10.

PMID:
18469349
[PubMed - indexed for MEDLINE]
Free Article
10.

Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia.

Anagnostopoulos A, Hari PN, Pérez WS, Ballen K, Bashey A, Bredeson CN, Freytes CO, Gale RP, Gertz MA, Gibson J, Goldschmidt H, Lazarus HM, McCarthy PL, Reece DE, Vesole DH, Giralt SA.

Biol Blood Marrow Transplant. 2006 Aug;12(8):845-54.

PMID:
16864055
[PubMed - indexed for MEDLINE]
11.

Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma.

Hosing C, Saliba RM, McLaughlin P, Andersson B, Rodriguez MA, Fayad L, Cabanillas F, Champlin RE, Khouri IF.

Ann Oncol. 2003 May;14(5):737-44.

PMID:
12702528
[PubMed - indexed for MEDLINE]
Free Article
12.

Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed.

Fung HC, Cohen S, Rodriguez R, Smith D, Krishnan A, Somlo G, Sahebi F, Senitzer D, O'Donnell MR, Stein A, Snyder DS, Spielberger R, Bhatia R, Falk P, Molina A, Nademanee A, Parker P, Kogut N, Popplewell L, Vora N, Margolin K, Forman SJ.

Biol Blood Marrow Transplant. 2003 Oct;9(10):649-56.

PMID:
14569561
[PubMed - indexed for MEDLINE]
13.

Patients' perception of health-related quality of life during the first year after autologous and allogeneic stem cell transplantation.

Andersson I, Ahlberg K, Stockelberg D, Persson LO.

Eur J Cancer Care (Engl). 2011 May;20(3):368-79. doi: 10.1111/j.1365-2354.2009.01174.x.

PMID:
20345452
[PubMed - indexed for MEDLINE]
14.

Patients' psychosocial concerns following stem cell transplantation.

Andrykowski MA, Cordova MJ, Hann DM, Jacobsen PB, Fields KK, Phillips G.

Bone Marrow Transplant. 1999 Nov;24(10):1121-9.

PMID:
10578162
[PubMed - indexed for MEDLINE]
Free Article
15.

Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study.

Thomas X, Suciu S, Rio B, Leone G, Broccia G, Fillet G, Jehn U, Feremans W, Meloni G, Vignetti M, de Witte T, Amadori S.

Haematologica. 2007 Mar;92(3):389-96.

PMID:
17339189
[PubMed - indexed for MEDLINE]
Free Article
16.

A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma.

Levine JE, Harris RE, Loberiza FR Jr, Armitage JO, Vose JM, Van Besien K, Lazarus HM, Horowitz MM, Bashey A, Bolwell BJ, Burns LJ, Cairo MS, Champlin RE, Freytes CO, Gibson J, Goldstein SC, Laughlin MJ, Lister J, Marks DI, Maziarz RT, Miller AM, Milone GA, Pavlovsky S, Pecora AL, Rizzo JD, Schiller G, Schouten HC, Zhang MJ; Lymphoma Study Writing Committee, International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry.

Blood. 2003 Apr 1;101(7):2476-82. Epub 2002 Nov 27.

PMID:
12456505
[PubMed - indexed for MEDLINE]
Free Article
17.

Discrepancies between patient and physician estimates for the success of stem cell transplantation.

Lee SJ, Fairclough D, Antin JH, Weeks JC.

JAMA. 2001 Feb 28;285(8):1034-8.

PMID:
11209174
[PubMed - indexed for MEDLINE]
18.

Allogeneic or autologous stem cell transplantation (SCT) for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma: a single-centre experience.

Nachbaur D, Oberaigner W, Fritsch E, Nussbaumer W, Gastl G.

Eur J Haematol. 2001 Jan;66(1):43-9.

PMID:
11168507
[PubMed - indexed for MEDLINE]
19.

Health-related quality of life in patients undergoing allogeneic stem cell transplantation after reduced intensity conditioning versus myeloablative conditioning.

Andersson I, Ahlberg K, Stockelberg D, Brune M, Persson LO.

Cancer Nurs. 2009 Jul-Aug;32(4):325-34. doi: 10.1097/NCC.0b013e31819b5c81.

PMID:
19444087
[PubMed - indexed for MEDLINE]
20.

Quality of life and difficulties of patients encountered after autologous stem cell transplantation.

Kav S, Aslan O, Tekin F, Yesil H, Meral C, Ozturk U, Bulut Z, Enaboifo A, Yazar B.

J BUON. 2009 Oct-Dec;14(4):673-80.

PMID:
20148461
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk